4:32 PM ET
10-Q
Financial Results
LENSAR Q3 2026 Results: Net Loss of $4.72M, Loss Widens
LENSAR, Inc. is focused on the commercialization of its ALLY Robotic Cataract Laser System while navigating the aftermath of a terminated Merger Agreement. The company continues to report operating losses and emphasizes risks related to macroeconomic conditions, regulatory clearances, and patient willingness to pay for advanced cataract procedures.
- Key figure
- Net loss $4.72M